You are here:Home-Chemical Inhibitors & Agonists-Immunology/Inflammation-PD-1/PD-L1-ZE132
ZE132

Chemical Structure : ZE132

CAS No.: 2566710-63-0

ZE132 (ZE 132)

Catalog No.: PC-72764Not For Human Use, Lab Use Only.

ZE132 is a potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with IC50 of <0.1 nM.

Packing Price Stock Quantity
25 mg Get quote
100 mg Get quote
250 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

ZE132 is a potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with IC50 of <0.1 nM.
ZE132 effectively inhibits the PD-1/PD-L1 interactions in vitro, and has a potent affinity to PD-L1.
ZE132 shows robust anti-tumour effects in vivo, better than anti-PD-1 antibody.
ZE132 treatment promotes cytotoxic T-cell tumour infiltration and induces IL-2 expression.
ZE132 elicits strong inhibitory effects on the mRNA expression of TGF-β.

Physicochemical Properties

M.Wt 721.266
Formula C37H41ClN4O7S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-((5-Chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)(3-(dimethylamino)propyl)amino)ethane-1-sulfonic acid

References

1. Chenglong Liu, et al. Br J Pharmacol. 2021 Jul;178(13):2651-2670.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: